‘Not necessarily benign’: Geriatricians address safety as seniors turn to CBD for chronic conditions
By
Alicia Lasek
Apr 29, 2021
Seniors increasingly are using cannabidiol, or CBD, to help manage a variety of chronic disease symptoms. A new paper from the Gerontological Society of America tackles key questions about safety and side...
Expanded Xofluza approval includes seniors at risk of flu complications
By
Alicia Lasek
Oct 20, 2019
The U.S. Food & Drug Administration has expanded approval of the oral antiviral drug Xofluza for people at high risk of flu complications.
Anticoagulants advised following certain COVID-19 acute-care stays
By
Alicia Lasek
Nov 29, 2021
Clinicians disagree about the need for continued anticoagulation therapy to reduce blood clot risks following COVID-19 hospitalization. A new study suggests that patients with certain medical histories...
Berries, mixed foods may raise Listeria risk for LTC facilities, outbreak analysis finds
By
Alicia Lasek
Oct 19, 2021
Long-term care facilities may be susceptible to listeriosis outbreaks, investigators say. These infections tend to crop up as single but severe cases over a prolonged time period.
Lower-limb muscle function may get a boost from daily dose of leafy greens
By
Alicia Lasek
Mar 25, 2021
Nitrate supplements have been shown to improve muscle and vascular function, but a new study shows that the same benefits can be had from consuming a small daily serving of leafy green vegetables.
Long-term care left behind in race to nab COVID monoclonal antibodies: report
Nov 02, 2021
Delayed shipments of antibody doses are putting residents’ lives at risk after federal authorities barred direct orders of the drugs, LTC clinicians say.
Stroke survivors double functional improvement rate with vagus nerve stimulation: study
By
Alicia Lasek
Apr 27, 2021
Vagus nerve stimulation during post-stroke rehabilitation can significantly boost the improvement rate of arm and hand function, a new study finds.
Providers with adequate equipment and training stay COVID-19 free: study
By
Alicia Lasek
Jul 08, 2020
None of the 420 doctors and nurses participating in the study developed COVID-19-related symptoms or tested positive for antibodies after working in a high-risk environment.
Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
Survey: Short-stay residents want more help with meds, clinician connections upon discharge
By
Alicia Lasek
Nov 03, 2021
Fully 80% of respondents said they received and understood their discharge instructions. But at least two-thirds would have liked more help with their medication regimen, physician referrals, and other...